DaVita Inc. logo
DaVita Inc. (DVA)
Compare

DaVita Inc. (DVA) PE Ratio: 20.99

popular:market cap|pe ratio|revenue|price history|total return

Is DaVita Inc.’s P/E ratio high or low?

DaVita Inc.'s P/E ratio of 20.99 is 41% above its 5-year average of 14.84, near the high end of its 5-year range (9.05–22.40).

As of Monday, June 15, 2026. 45.25% above its 12-month average of 14.45.

PE Ratio (20.99) = Close Price ($208.66) / Diluted TTM EPS ($9.94)

PEG Ratio|P/B Ratio|EPS|All Metrics

DVA PE Ratio Chart

DVA PE Ratio
20.99+54.22% 1Y
Zoom

DVA Average PE Ratio Chart

DVA Current vs Average PE Ratio Chart

DVA PE Ratio Metrics

PE RATIO

20.99

PE RATIO AVG TTM

14.45

PE RATIO AVG 3Y

15.87

PE RATIO AVG 5Y

14.84

PE RATIO AVG 10Y

15.75

PE RATIO AVG 15Y

18.76

PE RATIO AVG 20Y

17.85

CURRENT VS TTM AVG

+45.25%

CURRENT VS 3Y AVG

+32.25%

CURRENT VS 5Y AVG

+41.48%

CURRENT VS 10Y AVG

+33.27%

CURRENT VS 15Y AVG

+11.87%

CURRENT VS 20Y AVG

+17.59%

DVA Competitors' PE Ratio

NAMEMARKET CAPPE RATIOTTM3Y5Y
DaVita Inc. (DVA)$13.40B20.9914.4515.8714.84
The Cooper Companies, Inc. (COO)vs ›$13.24B57.5337.1047.5031.28
Solventum Corporation (SOLV)vs ›$13.66B9.6518.7817.0617.06
Align Technology, Inc. (ALGN)vs ›$12.52B29.3429.2642.8347.70
Baxter International Inc. (BAX)vs ›$10.77BN/A44.5334.4137.43
Walgreens Boots Alliance, Inc. (WBA)vs ›$10.37BN/A33.4814.6325.08
Hologic, Inc. (HOLX)vs ›$16.97B31.6728.1230.0822.83
Charles River Laboratories International, Inc. (CRL)vs ›$9.03BN/A225.6691.3972.20
Tempus AI, Inc. (TEM)vs ›$8.35BN/AN/AN/AN/A
Bio-Rad Laboratories, Inc. (BIO)vs ›$7.73B47.1123.9823.9812.19

P/E vs. its own history

At 21.0, P/E is richer than usual, sitting higher than 71% of its 20-year history.

20-year low

8.3

median

17.7

20-year high

83.5

cheaperricher

P/E Comparison

Trailing P/E

21.0

Forward P/E

14.1

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$208.66

÷

Forward EPS (Est.)

$14.85

=

Forward P/E

14.05

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

DaVita Inc. PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

DaVita Inc. PE Ratio FAQ

What is the P/E ratio for DaVita Inc. (DVA)?
The P/E ratio for DVA stock is 20.99.
Is DaVita Inc.'s P/E ratio high or low?
DaVita Inc.'s P/E ratio of 20.99 is 41% above its 5-year average of 14.84, near the high end of its 5-year range (9.05–22.40).
What is the TTM average P/E ratio for DaVita Inc. (DVA)?
The TTM average P/E ratio for DVA stock is 14.45.
What is the 3Y average P/E ratio for DaVita Inc. (DVA)?
The 3Y average P/E ratio for DVA stock is 15.87.
What is the 5Y average P/E ratio for DaVita Inc. (DVA)?
The 5Y average P/E ratio for DVA stock is 14.84.
What is the 10Y average P/E ratio for DaVita Inc. (DVA)?
The 10Y average P/E ratio for DVA stock is 15.75.
What is the 15Y average P/E ratio for DaVita Inc. (DVA)?
The 15Y average P/E ratio for DVA stock is 18.76.
What is the 20Y average P/E ratio for DaVita Inc. (DVA)?
The 20Y average P/E ratio for DVA stock is 17.85.

DaVita Inc. PE Ratio History

DATEPE RATIO
2026-06-1220.99
2026-06-1120.51
2026-06-1019.97
2026-06-0919.94
2026-06-0819.32
2026-06-0519.33
2026-06-0419.33
2026-06-0319.62
2026-06-0218.90
2026-06-0119.10
2026-05-2919.55
2026-05-2819.83
2026-05-2719.61
2026-05-2619.68
2026-05-2219.97
2026-05-2119.99
2026-05-2019.81
2026-05-1919.58
2026-05-1820.07
2026-05-1520.09
2026-05-1419.37
2026-05-1319.93
2026-05-1220.18
2026-05-1120.01
2026-05-0819.98
2026-05-0719.74
2026-05-0619.51
2026-05-0515.80
2026-05-0416.99
2026-05-0116.72
2026-04-3017.10
2026-04-2916.76
2026-04-2816.55
2026-04-2716.54
2026-04-2416.74
2026-04-2317.09
2026-04-2216.80
2026-04-2116.53
2026-04-2016.46
2026-04-1716.31
2026-04-1616.33
2026-04-1515.94
2026-04-1416.48
2026-04-1316.71
2026-04-1016.54
2026-04-0916.61
2026-04-0816.37
2026-04-0716.50
2026-04-0616.55
2026-04-0216.05
2026-04-0116.58
2026-03-3116.94
2026-03-3016.80
2026-03-2717.03
2026-03-2617.28
2026-03-2517.10
2026-03-2416.90
2026-03-2316.78
2026-03-2016.46
2026-03-1916.51
2026-03-1816.41
2026-03-1716.54
2026-03-1616.34
2026-03-1316.62
2026-03-1216.88
2026-03-1117.07
2026-03-1016.71
2026-03-0916.82
2026-03-0616.62
2026-03-0516.53
2026-03-0417.07
2026-03-0316.79
2026-03-0216.98
2026-02-2717.23
2026-02-2616.82
2026-02-2516.48
2026-02-2416.64
2026-02-2316.68
2026-02-2016.62
2026-02-1916.24
2026-02-1816.29
2026-02-1716.58
2026-02-1316.42
2026-02-1216.53
2026-02-1115.91
2026-02-1014.34
2026-02-0914.18
2026-02-0614.50
2026-02-0515.37
2026-02-0414.63
2026-02-0313.88
2026-02-0211.45
2026-01-3011.26
2026-01-2911.04
2026-01-2810.90
2026-01-2710.88
2026-01-2611.07
2026-01-2311.13
2026-01-2211.24
2026-01-2110.95
2026-01-2010.70
2026-01-1610.79
2026-01-1510.90
2026-01-1410.70
2026-01-1310.76
2026-01-1211.34
2026-01-0911.48
2026-01-0811.60
2026-01-0711.43
2026-01-0611.81
2026-01-0511.73
2026-01-0211.79
2025-12-3111.70
2025-12-3011.72
2025-12-2911.69
2025-12-2611.74
2025-12-2411.78
2025-12-2311.81
2025-12-2212.00
2025-12-1911.86
2025-12-1811.96
2025-12-1712.20
2025-12-1612.15
2025-12-1512.36
2025-12-1212.50
2025-12-1112.39
2025-12-1012.22
2025-12-0912.02
2025-12-0812.05
2025-12-0512.09
2025-12-0412.08
2025-12-0312.18
2025-12-0212.27
2025-12-0112.28
2025-11-2812.33
2025-11-2612.37
2025-11-2512.50
2025-11-2412.31
2025-11-2112.38
2025-11-2011.88
2025-11-1911.86
2025-11-1812.00
2025-11-1712.08
2025-11-1412.52
2025-11-1312.67
2025-11-1212.73
2025-11-1112.59
2025-11-1012.38
2025-11-0712.74
2025-11-0612.52
2025-11-0512.48
2025-11-0412.36
2025-11-0312.26
2025-10-3112.26
2025-10-3012.23
2025-10-2913.03
2025-10-2812.74
2025-10-2712.74
2025-10-2412.70
2025-10-2312.59
2025-10-2212.69
2025-10-2112.63
2025-10-2012.59
2025-10-1712.38
2025-10-1612.32
2025-10-1512.39
2025-10-1412.45
2025-10-1312.18
2025-10-1012.19
2025-10-0912.43
2025-10-0812.58
2025-10-0712.88
2025-10-0612.60
2025-10-0312.90
2025-10-0212.99
2025-10-0113.06
2025-09-3013.06
2025-09-2912.84
2025-09-2612.86
2025-09-2512.81
2025-09-2413.14
2025-09-2313.06
2025-09-2212.90
2025-09-1912.80
2025-09-1812.81
2025-09-1712.59
2025-09-1612.79
2025-09-1512.88
2025-09-1213.09
2025-09-1113.10
2025-09-1013.00
2025-09-0913.44
2025-09-0813.23
2025-09-0513.56
2025-09-0413.33
2025-09-0313.37
2025-09-0213.47
2025-08-2913.55
2025-08-2813.38
2025-08-2713.53
2025-08-2613.64
2025-08-2513.50
2025-08-2213.80
2025-08-2113.53
2025-08-2013.51
2025-08-1913.44
2025-08-1813.10
2025-08-1513.31
2025-08-1413.21
2025-08-1313.24
2025-08-1212.99
2025-08-1112.69
2025-08-0812.73
2025-08-0712.56
2025-08-0612.57
2025-08-0513.82
2025-08-0413.83
2025-08-0113.72
2025-07-3113.91
2025-07-3014.33
2025-07-2914.47
2025-07-2814.40
2025-07-2514.39
2025-07-2414.35
2025-07-2315.00
2025-07-2214.47
2025-07-2113.82
2025-07-1813.99
2025-07-1714.21
2025-07-1613.90
2025-07-1513.93
2025-07-1414.21
2025-07-1114.13
2025-07-1014.22
2025-07-0914.06
2025-07-0814.25
2025-07-0714.15
2025-07-0314.13
2025-07-0214.13
2025-07-0114.54
2025-06-3014.12
2025-06-2714.04
2025-06-2613.98
2025-06-2513.91
2025-06-2413.97
2025-06-2313.51
2025-06-2013.57
2025-06-1813.46
2025-06-1713.53
2025-06-1613.66
2025-06-1313.49
2025-06-1213.61
2025-06-1113.69
2025-06-1013.79
2025-06-0913.66
2025-06-0613.67
2025-06-0513.65
2025-06-0413.55
2025-06-0313.48
2025-06-0213.32

Showing the most recent 260 of 5,033 data points. The chart above shows the full history.

Related Metrics

PEG RatioP/B RatioEPSAll Metrics
See the Lowest P/E Ratio Stocks ranking →

About DaVita Inc.

DaVita Inc. specializes in delivering essential kidney dialysis treatments and comprehensive renal care to individuals grappling with chronic kidney failure. The company primarily operates an extensive network of outpatient dialysis centers, supplementing this with services provided in hospital inpatient settings and within patients' homes. Beyond direct patient treatment, DaVita manages its own diagnostic laboratories, performing routine tests vital for dialysis patients, alongside other physician-ordered laboratory analyses specifically for those with end-stage renal disease (ESRD). The firm also offers administrative and management support to various other outpatient dialysis facilities. Its broad spectrum of offerings extends to chronic disease management programs, supporting a substantial patient cohort; by year-end 2021, this included 16,000 patients enrolled in risk-based integrated care models and an additional 7,000 in other integrated care arrangements. Further specialized services encompass vascular access interventions, clinical research initiatives, direct physician support, and a complete suite of holistic kidney care solutions. As of December 31, 2021, DaVita's footprint across the United States comprised 2,815 outpatient dialysis centers, collectively serving approximately 203,100 patients. Globally, the company operated 339 outpatient dialysis centers spread across ten countries outside the U.S., attending to roughly 39,900 patients. Moreover, it furnished acute inpatient dialysis services and related laboratory work in around 850 U.S. hospitals. Founded in 1994, DaVita Inc. maintains its headquarters in Denver, Colorado. The company rebranded to its current name in September 2016, having previously been known as DaVita HealthCare Partners Inc.

Denver, CO
76,000 employees
www.davita.com
Healthcare / Medical - Care Facilities
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Javier J. Rodriguez
View full financials